In the realm of surgical oncology, randomized controlled trials (RCTs) often face recruitment and standardization challenges. This study dives into hepatopancreatobiliary (HPB) cancer surgery, spotlighting the pivotal role of large databases. While RCTs provide crucial evidence, big data steps in where they fall short. Beyond justifying current practices, this research maps the future of HPB oncology, leveraging expansive datasets to unravel complexities, inform health policies, and address gaps inaccessible to traditional trials.
Review by Shrikhande SV, Kunte AR (…) Bhandare MS et 2 al. in J Surg Oncol
© 2023 Wiley Periodicals LLC.